Literature DB >> 9144868

Immunopathology of human immunodeficiency virus infection in the gastrointestinal tract.

T Schneider1, R Ullrich, M Zeitz.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9144868     DOI: 10.1007/bf00824056

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  117 in total

1.  T cell differentiation antigens on lymphocytes in the human intestinal lamina propria.

Authors:  H L Schieferdecker; R Ullrich; H Hirseland; M Zeitz
Journal:  J Immunol       Date:  1992-10-15       Impact factor: 5.422

2.  CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual.

Authors:  C E Mackewicz; H W Ortega; J A Levy
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

3.  Mucosal atrophy is associated with loss of activated T cells in the duodenal mucosa of human immunodeficiency virus (HIV)-infected patients.

Authors:  R Ullrich; M Zeitz; W Heise; M L'age; K Ziegler; C Bergs; E O Riecken
Journal:  Digestion       Date:  1990       Impact factor: 3.216

4.  Predominance of helper-inducer T cells in mesenteric lymph nodes and intestinal lamina propria of normal nonhuman primates.

Authors:  S P James; A S Graeff; M Zeitz
Journal:  Cell Immunol       Date:  1987-07       Impact factor: 4.868

5.  The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA.

Authors:  C S Kaetzel; J K Robinson; K R Chintalacharuvu; J P Vaerman; M E Lamm
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis.

Authors:  G Cozon; F Biron; M Jeannin; D Cannella; J P Revillard
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

7.  Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells.

Authors:  E Maggi; M Mazzetti; A Ravina; F Annunziato; M de Carli; M P Piccinni; R Manetti; M Carbonari; A M Pesce; G del Prete
Journal:  Science       Date:  1994-07-08       Impact factor: 47.728

8.  Persistent diarrhoea in Zairian AIDS patients: an endoscopic and histological study.

Authors:  R Colebunders; K Lusakumuni; A M Nelson; P Gigase; I Lebughe; E van Marck; B Kapita; H Francis; J J Salaun; T C Quinn
Journal:  Gut       Date:  1988-12       Impact factor: 23.059

9.  Stool viruses, coinfections, and diarrhea in HIV-infected patients. Berlin Diarrhea/Wasting Syndrome Study Group.

Authors:  W Schmidt; T Schneider; W Heise; T Weinke; H J pple; M Stöffler-Meilicke; O Liesenfeld; R Ignatius; M Zeitz; E O Riecken; R Ullrich
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-09

10.  Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. The Berlin Diarrhoea/Wasting Syndrome Study Group.

Authors:  T Schneider; R Ullrich; C Bergs; W Schmidt; E O Riecken; M Zeitz
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

View more
  5 in total

1.  Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease.

Authors:  B Schramm; M L Penn; R F Speck; S Y Chan; E De Clercq; D Schols; R I Connor; M A Goldsmith
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  HIV-1 gp120 accelerates Fas-mediated activation-induced human lamina propria T cell apoptosis.

Authors:  M Boirivant; M Viora; L Giordani; A L Luzzati; A M Pronio; C Montesani; O Pugliese
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

3.  Lack of simian immunodeficiency virus (SIV) specific IgA response in the intestine of SIV infected rhesus macaques.

Authors:  F Schäfer; S Kewenig; N Stolte; C Stahl-Hennig; A Stallmach; F-J Kaup; M Zeitz; T Schneider
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

4.  Lack of immunotoxicity of saquinavir (Ro 31-8959) used alone or in double or triple combination with AZT and ddC.

Authors:  M Viora; G Di Genova; M G Quaranta; M Boirivant; B Camponeschi
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

Review 5.  Novel approaches to inhibit HIV entry.

Authors:  Chukwuka A Didigu; Robert W Doms
Journal:  Viruses       Date:  2012-02-21       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.